You are here

Prospective Evaluation of the Radiographic Efficacy of Enbrel

Last updated on March 20, 2019

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Rheumatoid Arthritis, Psoriasis Arthritis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Subject eligibility should be reviewed and documented by an appropriately qualified
member of the investigator's study team before subjects are included in the study.

- Evidence of a personally signed and dated informed consent document indicating that
the subject (or a legally acceptable representative) has been informed of all
pertinent aspects of the study is a requirement for inclusion into this study.

Subjects must meet all of the following inclusion criteria to be eligible for enrollment
into the study:

- Subjects who are willing and able to comply with scheduled visits, treatment plan,
laboratory tests, and other study procedures.

- Definitive diagnosis of RA or PsA.

- Eligible for Etanercept treatment according to Summary of Product Characteristics
(SmPC).

- Inclusion of subjects pretreated with other biologics other than Etanercept is
possible

- One plain radiograph of hands and feet (Anteroposterior) within 3 month prior to
initiation of treatment with Etanercept and one planned consecutive radiograph of hand
and feet taken over 12 to 18 months according to German recommendations for patients
treated with biologics.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Receipt of any investigational drug within 3 months of study inclusion.

- Exclusion Criteria according to the Enbrel® SmPC, with particular attention to:

- Hypersensitivity to the active substance (etanercept) or to any of the excipients.

- Sepsis or risk of sepsis.

- Active infections, including chronic or localised infections.

- Subjects who have received any previous treatment with etanercept

- Subjects who are investigational site staff members or subjects who are Pfizer
employees directly involved in the conduct of the trial.

NCT01623752
Pfizer
Completed
Prospective Evaluation of the Radiographic Efficacy of Enbrel

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Rheumatoid Arthritis
NCT03981900
All Genders
18+
Years
Multiple Sites
Crohn Desease, Ulcerative Colitis, Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis
NCT02925338
All Genders
6+
Years
Multiple Sites
Systemic Lupus Erythematosus, Rheumatoid Arthritis
NCT03334851
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now